Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival
Autor: | Yip Fk, Kim Sj, No-Hee Park, Goberdhan P. Dimri, Kang Mk, Christensen R, Shin Kh, Kim Rh, Han T |
---|---|
Rok vydání: | 2006 |
Předmět: |
keratinocytes
Cancer Research Tumor suppressor gene Cell Survival Cell Biology medicine.disease_cause Sensitivity and Specificity Cell Line 03 medical and health sciences RNA interference 0302 clinical medicine Proto-Oncogene Proteins Tumor Cells Cultured medicine Humans RNA Messenger Bmi-1 Molecular Diagnostics Cell Proliferation 030304 developmental biology Polycomb Repressive Complex 1 0303 health sciences Gene knockdown Staining and Labeling Oncogene Reverse Transcriptase Polymerase Chain Reaction Cell growth Gene Expression Profiling Gene Amplification Nuclear Proteins nutritional and metabolic diseases oral cancer Cell cycle Immunohistochemistry Gene Expression Regulation Neoplastic Repressor Proteins Cell Transformation Neoplastic p16INK4A medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis Cancer cell Immunology Carcinoma Squamous Cell Cancer research Mouth Neoplasms Carcinogenesis polycomb |
Zdroj: | British Journal of Cancer |
ISSN: | 1532-1827 0007-0920 |
DOI: | 10.1038/sj.bjc.6603529 |
Popis: | Bmi-1 is a polycomb group protein that was identified as c-myc cooperating oncogene in murine lymphomagenesis. The current study was undertaken to determine the role of Bmi-1 in human oral carcinogenesis. Bmi-1 protein and RNA expression levels were markedly enhanced in the cells of oral squamous cell carcinomas (OSCC) compared with that of normal human oral keratinocytes (NHOK). Enhanced-Bmi-1 expression was also detected in situ in the archived oral mucosal tissues with cancerous and precancerous histopathology, including that of mild epithelial dysplasia. Thus, Bmi-1 expression occurs at a very early stage in oral carcinogenesis. To determine the biological role of Bmi-1 in cell proliferation, endogenous Bmi-1 was knocked down in actively proliferating SCC4 cells and NHOK by RNA interference. After Bmi-1 knockdown, cell replication was severely retarded. However, the expression of p16(INK4A), a known cellular target of Bmi-1, was not changed in cells with or without Bmi-1 knockdown. Furthermore, Bmi-1 knockdown in HOK-16B-BaP-T cells, in which the p16(INK4A)/pRb pathway was abrogated, led to immediate arrest of replication and loss of viable cells. Thus, our data suggest that Bmi-1 may act through p16(INK4A)-independent pathways to regulate cellular proliferation during oral cancer progression. |
Databáze: | OpenAIRE |
Externí odkaz: |